The MIAT Prize 2019

Mobi Dx

Mobi Dx is developing point-of-care diagnostics that allow early detection of diseases by profiling their rheology using only a single droplet of blood on a smartphone. For example, cardiovascular diseases are one of the primary cause of death worldwide and will cost $1tr to the global economy by 2030. Both mortality and morbidity are greatly reduced through early diagnosis especially if coupled with therapeutic treatment and /or behavioural change.

Mobi Dx uses smartphone technology to measure viscosity from a single droplet of blood on a disposable platform, giving the patient and healthcare professionals important information that can drive treatment and prevention.

Mobi Dx, finalist 2018
Mobi Dx, finalist 2018
Morgan Innovation & Technology

Morgan Innovation & Technology Ltd © 2019
All rights reserved.